| 6.03 Delayed Data As of Jul 15 |  +0.42 / +7.49%Today’s Change | 3.22 Today|||52-Week Range 11.34 | +64.31% Year-to-Date |
| Previous close | 5.61 |
| Today’s open | 5.61 |
| Day’s range | 5.60 - 6.15 |
| Volume | 237,766 |
| Average volume (3 months) | 142,375 |
| Market cap | $164.7M |
| Earnings growth (last year) | +37.27% |
| Earnings growth (this year) | +1.61% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.49 |
| Today’s change | Today’s % change | |
|---|---|---|
| NBRVNabriva Therapeutics... | -0.01 | -0.41% |
| AXGTAxovant Gene Therapi... | -0.02 | -0.27% |
| IDYAIdeaya Biosciences I... | -0.31 | -3.60% |
| CMRXChimerix Inc | 0.00 | 0.00% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$46.9M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Richard A. Miller |
CFO & Principal Accounting Officer Leiv Lea |
Corporate headquarters Burlingame, California |
